Angela Emser

3.3k total citations · 1 hit paper
31 papers, 2.2k citations indexed

About

Angela Emser is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Angela Emser has authored 31 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Angela Emser's work include Glioma Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (9 papers) and Diabetes Treatment and Management (8 papers). Angela Emser is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (9 papers) and Diabetes Treatment and Management (8 papers). Angela Emser collaborates with scholars based in Germany, United States and Switzerland. Angela Emser's co-authors include Stefan Rutkowski, Monika Warmuth‐Metz, Torsten Pietsch, Maximilian von Eynatten, Niels Soerensen, Hans‐Juergen Woerle, Rolf D. Kortmann, R Kolb, U Gebhardt and Joachim Kuehl and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Angela Emser

31 papers receiving 2.2k citations

Hit Papers

Treatment of Early Childhood Medulloblastoma by Postopera... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
    2005 505 citations Stefan Rutkowski, U. Bode et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Emser Germany 19 1.2k 821 804 550 322 31 2.2k
Roberta P. Glick United States 26 277 0.2× 439 0.5× 505 0.6× 321 0.6× 274 0.9× 79 1.8k
Anat Ben-Shlomo United States 30 408 0.3× 495 0.6× 1.7k 2.2× 201 0.4× 682 2.1× 72 2.5k
S Stefanko Netherlands 19 351 0.3× 298 0.4× 460 0.6× 449 0.8× 250 0.8× 45 1.5k
Stephen T. Magill United States 27 507 0.4× 474 0.6× 387 0.5× 894 1.6× 741 2.3× 132 2.4k
Jürgen Honegger Germany 33 687 0.6× 254 0.3× 2.0k 2.5× 411 0.7× 883 2.7× 99 2.9k
Byung-Kyu Cho South Korea 26 532 0.4× 254 0.3× 151 0.2× 588 1.1× 325 1.0× 66 1.7k
Whitney W. Woodmansee United States 24 239 0.2× 183 0.2× 1.1k 1.4× 144 0.3× 355 1.1× 48 1.5k
Zoltán Patay United States 25 740 0.6× 462 0.6× 51 0.1× 456 0.8× 136 0.4× 105 2.0k
Tetsuya Ueba Japan 23 200 0.2× 662 0.8× 93 0.1× 478 0.9× 203 0.6× 112 1.8k
Henry W. S. Schroeder Germany 23 205 0.2× 261 0.3× 138 0.2× 533 1.0× 603 1.9× 111 1.9k

Countries citing papers authored by Angela Emser

Since Specialization
Citations

This map shows the geographic impact of Angela Emser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Emser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Emser more than expected).

Fields of papers citing papers by Angela Emser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Emser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Emser. The network helps show where Angela Emser may publish in the future.

Co-authorship network of co-authors of Angela Emser

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Emser. A scholar is included among the top collaborators of Angela Emser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Emser. Angela Emser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eynatten, Maximilian von, Yan Gong, Angela Emser, & Hans‐Juergen Woerle. (2013). Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials. Cardiovascular Diabetology. 12(1). 60–60. 38 indexed citations
2.
Prato, Stefano Del, Marja‐Riitta Taskinen, David R. Owens, et al.. (2013). Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: Pooled analysis of data from three placebo-controlled phase III trials. Journal of Diabetes and its Complications. 27(3). 274–279. 16 indexed citations
3.
Groop, Per‐Henrik, Mark E. Cooper, Vlado Perkovic, et al.. (2013). Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction. Diabetes Care. 36(11). 3460–3468. 243 indexed citations
4.
Friedrich, Christian, Angela Emser, Hans‐Juergen Woerle, & Ulrike Graefe‐Mody. (2013). Renal Impairment Has No Clinically Relevant Effect on the Long-Term Exposure of Linagliptin in Patients With Type 2 Diabetes. American Journal of Therapeutics. 20(6). 618–621. 32 indexed citations
5.
Schernthaner, Guntram, Anthony Barnett, Angela Emser, et al.. (2012). Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 14(5). 470–478. 80 indexed citations
6.
Hoff, Katja von, Bernward Hinkes, André O. von Bueren, et al.. (2011). Frequency, Risk‐Factors and Survival of Children With Atypical Teratoid Rhabdoid Tumors (AT/RT) of the CNS Diagnosed between 1988 and 2004, and Registered to the German HIT Database. Pediatric Blood & Cancer. 57(6). 978–985. 95 indexed citations
7.
Kortmann, Rolf‐D., Torsten Pietsch, Angela Emser, et al.. (2011). Impact of chemotherapy on disseminated low‐grade glioma in children and adolescents: Report from the HIT‐LGG 1996 trial. Pediatric Blood & Cancer. 56(7). 1046–1054. 42 indexed citations
8.
Rutkowski, Stefan, Katja von Hoff, Angela Emser, et al.. (2010). Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis. Journal of Clinical Oncology. 28(33). 4961–4968. 201 indexed citations
9.
Rutkowski, Stefan, Nicolas U. Gerber, Katja von Hoff, et al.. (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncology. 11(2). 201–210. 107 indexed citations
10.
Grotzer, Michael A., Katja von Hoff, André O. von Bueren, et al.. (2007). Which Clinical and Biological Tumor Markers Proved Predictive in the Prospective Multicenter Trial HIT’91 - Implications for Investigating Childhood Medulloblastoma. Klinische Pädiatrie. 219(6). 312–317. 9 indexed citations
11.
Wagner, Sabine, Monika Warmuth‐Metz, Angela Emser, et al.. (2006). Treatment options in childhood pontine gliomas. Journal of Neuro-Oncology. 79(3). 281–287. 57 indexed citations
12.
Müller, Hermann L., U Gebhardt, Fabian Pöhl, et al.. (2006). Relapse Pattern After Complete Resection and Early Progression After Incomplete Resection of Childhood Craniopharyngioma. Klinische Pädiatrie. 218(6). 315–320. 36 indexed citations
13.
Müller, Hermann L., U Gebhardt, Andreas Faldum, et al.. (2006). Melatonin Treatment in Obese Patients with Childhood Craniopharyngioma and Increased Daytime Sleepiness. Cancer Causes & Control. 17(4). 583–589. 95 indexed citations
14.
Müller, Hermann L., Angela Emser, Andreas Faldum, et al.. (2005). Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Child s Nervous System. 21(11). 975–980. 95 indexed citations
15.
Rutkowski, Stefan, U. Bode, Frank Deinlein, et al.. (2005). Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone. New England Journal of Medicine. 352(10). 978–986. 505 indexed citations breakdown →
16.
Müller, Hermann L., U Gebhardt, Andreas Faldum, et al.. (2005). Functional capacity and body mass index in patients with sellar masses—cross-sectional study on 403 patients diagnosed during childhood and adolescence. Child s Nervous System. 21(7). 539–545. 40 indexed citations
17.
Wagner, Sabine, Bernhard Erdlenbruch, Alfred Längler, et al.. (2004). Oral topotecan in children with recurrent or progressive high‐grade glioma. Cancer. 100(8). 1750–1757. 16 indexed citations
18.
Gnekow, Astrid, R.-D. Kortmann, Torsten Pietsch, & Angela Emser. (2004). Low Grade Chiasmatic-Hypothalamic Glioma - Carboplatin and Vincristin Chemotherapy Effectively Defers Radiotherapy within a Comprehensive Treatment Strategy. Klinische Pädiatrie. 216(6). 331–342. 105 indexed citations
19.
20.
Müller, Hermann L., Angela Emser, Andreas Faldum, et al.. (2004). Longitudinal Study on Growth and Body Mass Index before and after Diagnosis of Childhood Craniopharyngioma. The Journal of Clinical Endocrinology & Metabolism. 89(7). 3298–3305. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta P. Glick Breakdown of academic impact, for papers by Anat Ben-Shlomo Breakdown of academic impact, for papers by S Stefanko Breakdown of academic impact, for papers by Stephen T. Magill Breakdown of academic impact, for papers by Jürgen Honegger Breakdown of academic impact, for papers by Byung-Kyu Cho Breakdown of academic impact, for papers by Whitney W. Woodmansee Breakdown of academic impact, for papers by Zoltán Patay Breakdown of academic impact, for papers by Tetsuya Ueba Breakdown of academic impact, for papers by Henry W. S. Schroeder
Rankless by CCL
2026